Showing posts with label Taser. Show all posts
Showing posts with label Taser. Show all posts

Friday, July 11, 2008

Finally - Port24 Update

Let's see where we're at, about two months into the Portfolio.

On 7/3/08 I had bought 400 Syneron for 15.04 and 400 more Elan for 33.70. So, I now have the following stocks (number in parentheses are the number of calls sold against them)

2000 SUPG (-20), 2000 NBIX, 600 ELN, 2000 DNDN (-10), 1200 TASR, 2000 ARNA, 1000 SGMO, 500 CRME (-5), 400 NVDA (-4), 400 ELOS
Cash balance is at $13,518.90, and the total market value is $100,875.92. That is a .87% return so far, which is obviously below my target. In my defense, I still have a number of July calls to sell -- which I hope to do today (time permitting at lunch!).

Supergen, Nvidia, and Taser are my biggest disappointments so far; Supergen missed on a clinical trial for Dacogen, Nvidia had a horrible quarter, and Taser lost the first lawsuit (out of 71 verdicts so far). Honestly, I will probably buy back the Supergen calls at a profit, and sell Supergen and Taser at a loss. I will make a final determination next week...

Elan is the biggest winner so far, having bought two sets of Elan that I've kept at $27.30 and $33.70, and the price now being $36.82. I am looking to crest $40 at the end of the month and depending on a spike, if any, following the ICAD results I will probably sell more calls on these shares at the next-higher $5 exercise price.

Regards,
Trond

Thursday, June 26, 2008

June Update for Port 24

June expiration came and went -- hoo boy do I wish I hadn't been conservative on the last batch of Elan calls!

The good news is that I made just over $6,000 in call premium -- although some of that is through future expiration months. I made around 3.4% for just this month, easily surpassing my 2% goal. Most of my Elan and all my Wyeth was called away.

The bad news is that Taser and Sangamo lost quite a bit of actual share price. So now I have to make the decision whether to hold, and sell calls quite a bit out-of-the-money (for much less than my 2%/month goal), wait to see if they gain some back, or simply sell for the loss and put the money to work in a hopefully better place. I haven't decided for sure yet, but I am fairly sure I'll be holding on to Sangamo and selling the Taser.

With the money raised by the exercise of Elan and Wyeth, I have today bought 500 Cardiome @ 9.19 (-5 @ $1 at $10 July strike) and 400 Nvidia @ 19.28 (-4 @ .70 at $20 July strike).

Regards,
Trond

Friday, May 23, 2008

Portfolio 24 additions

For the next few days I'll be adding a bunch of positions to the Port 24 -- so if you are reading this and don't care about the Port... my apologies in advance! To hit my target of 2% a month, I need to be nearly fully invested and thus the continuous updates.

I want to remind you that I AM tracking commissions behind the scenes -- if anyone wants to see exact numbers please comment or email and I will be happy to provide them. What I am doing is logging on to my brokerage account, getting the ask price on my stock, and then going to the option and getting the bid price. I am not doing enough activity to really move the market, but obviously my real world results may be off by a cent here or there. The nice thing about the real world is that I am more patient -- I actually enter a market price on the stock to assure myself of getting it and then add a limit buy at the next higher 5 or 10 cent increment and just wait for it to be eventually filled during normal daily price fluctuations. That can add another .5 to 1% returns just by being patient!

I just added:
1200 TASR at $7.20 and -12 QURFU (Jun08 $7.5) at $.30
2000 ARNA at $4.95 and -20 UGGFA (Jun08 $5) at $.25

I like Taser as a covered call stock because it is so volatile. I like the product itself and the continuous lawsuits against the company does not scare me. You just need to be patient with this one! We're on a recent dip so it's a perfect time to buy.
Arena has an obesity drug that it is probably going to be partnering soon (read -- a couple months more). Partnerships are where young biotechs can hit the motherlode -- cash up front, milestone payments, royalties, etc.

We're at:
2000 SUPG
2000 NBIX
400 ELN
2000 DNDN
1200 TASR
2000 ARNA
Cash: $48,566, and stocks worth approx $53,008, for a total of $101,574 after less than a month. Most of the stocks are underwater right now.

Regards,
Trond